Park Ha Biological Technology is trading 8.35% down at $0.33 as the stock continues to react to a class-action lawsuit alleging a fraudulent stock promotion scheme.
- The shares have faced significant volatility recently, previously dropping 7.9% on the legal news before a brief 5.33% recovery on August 03, 2026.
- Persistent legal uncertainty surrounding the fraud allegations continues to weigh on investor sentiment and drive price fluctuations.